KATHLEEN MENDOZA: Open Payments
NPI 1699227603 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 63 payments from 10 companies in 2025. Trend: 2023 $984 · 2024 $972 · 2025 $1,257
Food & beverage: $1,257
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $287 |
| Neurocrine BioSciences, Inc. | 7 | $268 |
| E.R. Squibb & Sons, L.L.C. | 10 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $171 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Lundbeck LLC | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, COBENFY, CAPLYTA, Auvelity, REXULTI, TRINTELLIX, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
